The Application of Intraoperative Nerve Monitoring in Assessing The Function of The Recurrent Laryngeal Nerve before and after Central Lymph Node Dissection_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 LIChang-lin , LIUXiao-li ,  SUNHui

Department of Thyroid Surgery, China-Japan Union Hospital of Jilin University; Jilin Provincial Key Laboratory of Surgical Translational Medicine; Jilin Provincial Engineering Laboratory of Thyroid Disease Prevention and Control, Changchun 130033, China;

Corresponding?author：

SUNHui, Email: sunhui1229@163.com

Keywords：

Thyroid cancer; Central lymph node dissection; Intraoperative nerve monitoring; Protection of recurrent laryngeal nerve

DOI：

10.7507/1007-9424.20160305

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To discuss whether central lymph node dissection (CLND) should be performed for papillary thyroid cancer (PTC) patients. Methods The related domestic and foreign literatures were retrieved, the necessity of CLND and the risk of recurrent laryngeal nerve (RLN) injury in CLND were reviewed, and the application value of intraoperative nerve monitoring (IONM) in CLND were analyzed. Results ① CLND can reduce the recurrence rate of PTC, improve postoperative survival rate, ease the difficulty of reoperation, and help to clarify tumor stage. ② CLND can increase the risk of RLN injury. ③ Application of INOM can decrease the risk of RLN injury. Conclusions The application of IONM during CLND effectively decrease the risk of RLN injury for surgeons, especially low seniority surgeons, and improve the survival quality and the prognosis. This combination will promote the implementation of routine CLND therapeutic strategy in thyroid cancer patients.

Citation： LI Chang-lin, LIU Xiao-li, SUN Hui. The Application of Intraoperative Nerve Monitoring in Assessing The Function of The Recurrent Laryngeal Nerve before and after Central Lymph Node Dissection. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2016, 23(10): 1188-1192. doi: 10.7507/1007-9424.20160305 Copy

1.	Davies L, Welch HG. Current thyroid cancer trends in the united states. JAMA Otolaryngol Head Neck Surg, 2014, 140(4):317-322.
2.	Siegel R, Ma J, Zou Z, et al. Cancer statistics. CA Cancer J Clin, 2014, 64(1):9-29.
3.	Forest VI, Clark JR, Ebrahimi A, et al. Central compartment dissection in thyroid papillary carcinoma. Ann Surg, 2011, 253(1):123-130.
4.	孫輝, 劉曉莉. 甲狀腺手術中喉返神經和喉上神經的保護. 中國實用外科雜志, 2012, 32(5):356-359.
5.	Mazzaferri E, Doherty G, Steward D. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid, 2009, 19(7):683-689.
6.	Haugen BR, Alexander EK, Bible KC, et al. 2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid, 2016, 26(1):1-133.
7.	滕衛平, 劉永鋒, 高明, 等. 甲狀腺結節和分化型甲狀腺癌診治指南. 中國腫瘤臨床, 2012, 39(17):1249-1272.
8.	Cooper D, Doherty GM, Haugen BR, et al. Revised american thyroid association management guidelines for patients for patients with thyroid nodules and differentiated thyroid cancer:the american thyroid association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, 19(11):1167-1214.
9.	Moo TA, McGill J, Allendorf J, et al. Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg, 2010, 34(6):1187-1191.
10.	Barczyński M, Konturek A, Stopa M, et al. Prophylactic central neck dissection for papillary thyroid cancer. Br J Surg, 2013, 100(3):410-418.
11.	Hartl DM, Mamelle E, Borget I, et al. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg, 2013, 37(8):1951-1958.
12.	Hartl DM, Leboulleux S, Al Ghuzlan A, et al. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg, 2012, 255(4):777-783.
13.	Xiao GZ, Gao L. Central lymph node metastasis:Is it a reliable indicator of lateral node involvement in papillary thyroid carcinoma? World J Surg, 2010, 34(2):237-241.
14.	Sancho JJ, Pascual-Damieta M, Pereira JA, et al. Risk factors for transient vocal cord palsy after thyroidectomy. Br J Surg, 2008, 95(8):961-967.
15.	Sywak M, Cornford L, Roach P, et al. Routine ipsilateral level Ⅵ lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery, 2006, 140(6):1000-1007.
16.	Podnos YD, Smith D, Wagman LD, et al. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg, 2005, 71(9):731-734.
17.	Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas:Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg, 2003, 237(3):399-407.
18.	Lang BH, Wong KP, Wan KY, et al. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma. Ann Surg Oncol, 2012, 19(1):60-67.
19.	Palestini N, Borasi A, Cestino L, et al. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg, 2008, 393(5):693-698.
20.	胡治華, 華清泉. 分化型甲狀腺癌cN0期Ⅵ區淋巴結清掃必要性的系統評價. 中國醫藥導報, 2014, 11(9):80-85.
21.	Barczyński M, Konturek A, Stopa M, et al. Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer. Langenbecks Arch Surg, 2014, 399(2):237-244.
22.	彭喆, 田文, 姚京, 等. cN0甲狀腺乳頭狀癌行中央區頸淋巴結清掃術的臨床研究. 中國普外基礎與臨床雜志, 2014, 21(5):618-622.
23.	Ji YB, Yoo HS, Song CM, et al. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma. Auris Nasus Larynx, 2016, 43(1):79-83.
24.	Giordano D, Valcavi R, Thompson GB, et al. Complications of central neck dissection in patients with papillary thyroid carcinoma:results of a study on 1087 patients and review of the literature. Thyroid, 2012, 22(9):911-917.
25.	Sanabria A, Silver CE, Suárez C, et al. Neuromonitoring of the laryngeal nerves in thyroid surgery:a critical appraisal of the literature. Eur Arch Otorhinolaryngol, 2013, 270(9):2383-2395.
26.	Noguchi S, Yamashita H, Uchino S, et al. Papillary microcarcinoma. World J Surg, 2008, 32(5):747-753.
27.	Hauch A, Al-Qurayshi Z, Randolph G, et al. Total thyroidectomy is associated with increased risk of complications for lowand high-volume surgeons. Ann Surg Oncol, 2014, 21(12):3844-3852.
28.	Lahey FH. Routine dissection and demonstration of the recurrent laryngeal never in subtotal thyroidectomy. Surg Gynecol Obstet, 1938, 66(4):775-777.
29.	Sheed DP, Burget GC. Identification of the recurrent laryngeal nerve. Arch Surg, 1996, 92(6):861-864.
30.	Flisberg K, Lindholm T. Electrical stimulation of the human recurrent laryngeal nerve during thyroid operation. Acta Otolaryngol Suppl, 1970, 263:63-67.
31.	中國醫師協會外科醫師分會甲狀腺外科醫師委員會. 甲狀腺及甲狀旁腺手術中神經電生理監測臨床指南(中國版). 中國實用外科雜志, 2013, 8(6):470-474.
32.	Randolph GW, Dralle H; International Intraoperative Monitoring Study G, et al. Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery:International standards guideline statement. Laryngoscope, 2011, 121 Suppl 1:S1-S16.
33.	Barczyński M, Konturek A, Cichon S. Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg, 2009, 96(3):240-246.
34.	Calò PG, Pisano G, Medas F, et al. Identification alone versus intraoperative neuromonitoring of the recurrent laryngeal nerve during thyroid surgery:Experience of 2034 consecutive patients. J Otolaryngol Head Neck Surg, 2014, 43:16.
35.	Barczyński M, Konturek A, Stopa M, et al. Clinical value of intraoperative neuromonitoring of the recurrent laryngeal nerves in improving outcomes of surgery for well-differentiated thyroid cancer. Pol Przegl Chir, 2011, 83(4):196-203.
36.	Neumann HJ. Intraoperative neurophysiological monitoring (IONM) of the recurrent laryngeal nerve and microdissection. Surgical techniques for decreasing the risk of recurrent laryngeal nerve paralysis. Laryngorhinootologie, 2000, 79(5):290-296.
37.	Chuang YC, Huang SM. Protective effect of intraoperative nerve monitoring against recurrent laryngeal nerve injury during re-exploration of the thyroid. World J Surg Oncol, 2013, 11:94.
38.	Hermann M, Hellebart C, Freissmuth M. Neuromonitoring in thyroid surgery:prospective evaluation of intraoperative electrophysiological responses for the prediction of recurrent laryngeal nerve injury. Ann Surg, 2004, 240(1):9-17.

1. Davies L, Welch HG. Current thyroid cancer trends in the united states. JAMA Otolaryngol Head Neck Surg, 2014, 140(4):317-322.
2. Siegel R, Ma J, Zou Z, et al. Cancer statistics. CA Cancer J Clin, 2014, 64(1):9-29.
3. Forest VI, Clark JR, Ebrahimi A, et al. Central compartment dissection in thyroid papillary carcinoma. Ann Surg, 2011, 253(1):123-130.
4. 孫輝, 劉曉莉. 甲狀腺手術中喉返神經和喉上神經的保護. 中國實用外科雜志, 2012, 32(5):356-359.
5. Mazzaferri E, Doherty G, Steward D. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid, 2009, 19(7):683-689.
6. Haugen BR, Alexander EK, Bible KC, et al. 2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid, 2016, 26(1):1-133.
7. 滕衛平, 劉永鋒, 高明, 等. 甲狀腺結節和分化型甲狀腺癌診治指南. 中國腫瘤臨床, 2012, 39(17):1249-1272.
8. Cooper D, Doherty GM, Haugen BR, et al. Revised american thyroid association management guidelines for patients for patients with thyroid nodules and differentiated thyroid cancer:the american thyroid association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, 19(11):1167-1214.
9. Moo TA, McGill J, Allendorf J, et al. Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg, 2010, 34(6):1187-1191.
10. Barczyński M, Konturek A, Stopa M, et al. Prophylactic central neck dissection for papillary thyroid cancer. Br J Surg, 2013, 100(3):410-418.
11. Hartl DM, Mamelle E, Borget I, et al. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg, 2013, 37(8):1951-1958.
12. Hartl DM, Leboulleux S, Al Ghuzlan A, et al. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg, 2012, 255(4):777-783.
13. Xiao GZ, Gao L. Central lymph node metastasis:Is it a reliable indicator of lateral node involvement in papillary thyroid carcinoma? World J Surg, 2010, 34(2):237-241.
14. Sancho JJ, Pascual-Damieta M, Pereira JA, et al. Risk factors for transient vocal cord palsy after thyroidectomy. Br J Surg, 2008, 95(8):961-967.
15. Sywak M, Cornford L, Roach P, et al. Routine ipsilateral level Ⅵ lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery, 2006, 140(6):1000-1007.
16. Podnos YD, Smith D, Wagman LD, et al. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg, 2005, 71(9):731-734.
17. Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas:Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg, 2003, 237(3):399-407.
18. Lang BH, Wong KP, Wan KY, et al. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma. Ann Surg Oncol, 2012, 19(1):60-67.
19. Palestini N, Borasi A, Cestino L, et al. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg, 2008, 393(5):693-698.
20. 胡治華, 華清泉. 分化型甲狀腺癌cN0期Ⅵ區淋巴結清掃必要性的系統評價. 中國醫藥導報, 2014, 11(9):80-85.
21. Barczyński M, Konturek A, Stopa M, et al. Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer. Langenbecks Arch Surg, 2014, 399(2):237-244.
22. 彭喆, 田文, 姚京, 等. cN0甲狀腺乳頭狀癌行中央區頸淋巴結清掃術的臨床研究. 中國普外基礎與臨床雜志, 2014, 21(5):618-622.
23. Ji YB, Yoo HS, Song CM, et al. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma. Auris Nasus Larynx, 2016, 43(1):79-83.
24. Giordano D, Valcavi R, Thompson GB, et al. Complications of central neck dissection in patients with papillary thyroid carcinoma:results of a study on 1087 patients and review of the literature. Thyroid, 2012, 22(9):911-917.
25. Sanabria A, Silver CE, Suárez C, et al. Neuromonitoring of the laryngeal nerves in thyroid surgery:a critical appraisal of the literature. Eur Arch Otorhinolaryngol, 2013, 270(9):2383-2395.
26. Noguchi S, Yamashita H, Uchino S, et al. Papillary microcarcinoma. World J Surg, 2008, 32(5):747-753.
27. Hauch A, Al-Qurayshi Z, Randolph G, et al. Total thyroidectomy is associated with increased risk of complications for lowand high-volume surgeons. Ann Surg Oncol, 2014, 21(12):3844-3852.
28. Lahey FH. Routine dissection and demonstration of the recurrent laryngeal never in subtotal thyroidectomy. Surg Gynecol Obstet, 1938, 66(4):775-777.
29. Sheed DP, Burget GC. Identification of the recurrent laryngeal nerve. Arch Surg, 1996, 92(6):861-864.
30. Flisberg K, Lindholm T. Electrical stimulation of the human recurrent laryngeal nerve during thyroid operation. Acta Otolaryngol Suppl, 1970, 263:63-67.
31. 中國醫師協會外科醫師分會甲狀腺外科醫師委員會. 甲狀腺及甲狀旁腺手術中神經電生理監測臨床指南(中國版). 中國實用外科雜志, 2013, 8(6):470-474.
32. Randolph GW, Dralle H; International Intraoperative Monitoring Study G, et al. Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery:International standards guideline statement. Laryngoscope, 2011, 121 Suppl 1:S1-S16.
33. Barczyński M, Konturek A, Cichon S. Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg, 2009, 96(3):240-246.
34. Calò PG, Pisano G, Medas F, et al. Identification alone versus intraoperative neuromonitoring of the recurrent laryngeal nerve during thyroid surgery:Experience of 2034 consecutive patients. J Otolaryngol Head Neck Surg, 2014, 43:16.
35. Barczyński M, Konturek A, Stopa M, et al. Clinical value of intraoperative neuromonitoring of the recurrent laryngeal nerves in improving outcomes of surgery for well-differentiated thyroid cancer. Pol Przegl Chir, 2011, 83(4):196-203.
36. Neumann HJ. Intraoperative neurophysiological monitoring (IONM) of the recurrent laryngeal nerve and microdissection. Surgical techniques for decreasing the risk of recurrent laryngeal nerve paralysis. Laryngorhinootologie, 2000, 79(5):290-296.
37. Chuang YC, Huang SM. Protective effect of intraoperative nerve monitoring against recurrent laryngeal nerve injury during re-exploration of the thyroid. World J Surg Oncol, 2013, 11:94.
38. Hermann M, Hellebart C, Freissmuth M. Neuromonitoring in thyroid surgery:prospective evaluation of intraoperative electrophysiological responses for the prediction of recurrent laryngeal nerve injury. Ann Surg, 2004, 240(1):9-17.

Previous Article
淺談細針穿刺活檢診斷甲狀腺微小癌的技巧
Next Article
Establishment of an Animal Model of Temporary Hypoparathyroidism Following Thyroid Operation in Rabbits

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

The Application of Intraoperative Nerve Monitoring in Assessing The Function of The Recurrent Laryngeal Nerve before and after Central Lymph Node Dissection

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content